Liangjiang New Area has added 12 new companies to its roster of "Little Giant" enterprises. These businesses are recognized for their leadership in niche markets, showcasing exceptional innovation capabilities, significant market share, mastery of critical technologies, and superior quality and efficiency.
Here are several highlights.
Chongqing iSIA BIO-Technology Co is celebrated for its commitment to the research, development, production, sales, and service of in vitro diagnostic (IVD) reagents and instruments.
The company's product range includes advanced quantum dot POCT and chemiluminescence technologies, with ongoing innovations in microbial detection and molecular diagnostics. Its patented Helicobacter pylori rapid typing test kits are utilized in over 30 countries and regions, addressing diagnostic needs in areas such as gastric function, early cancer detection, and bone metabolism.
Evaheart Medical has garnered attention with its flagship product, the Implantable Left Ventricular Assist Device, which stands as China's first and only approved long-term artificial heart.
The company has localized the core components of artificial hearts, creating a self-reliant industrial chain and breaking the longstanding monopoly of European and American companies in this field.
Chongqing Camyu Tech Co is a high-tech enterprise focused on the research, production, and service of digital imaging components. The company’s products are noted for their miniaturization, digitization, high precision, reliability, wide temperature range, and strong anti-interference capabilities.